JOHN BELMONT to Cost-Benefit Analysis
This is a "connection" page, showing publications JOHN BELMONT has written about Cost-Benefit Analysis.
Connection Strength
0.036
-
Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases. Genet Med. 2022 01; 24(1):109-118.
Score: 0.036
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.